Safety and efficacy of oral octreotide in acromegaly: Results of a multicenter phase III trial

Additional Metadata
Persistent URL	doi.org/10.1210/jc.2014-4113, hdl.handle.net/1765/84058
Journal	Journal of Clinical Endocrinology and Metabolism
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Melmed, S., Popovic, V., Bidlingmaier, M., Mercado, M., van der Lely, A.-J., Biermasz, N. R., Bolanowski, M., Coculescu, M., Schopohl, J., Racz, K., Glaser, B., Goth, M., Greenman, Y., Trainer, P., Mezosi, E., Shimon, I., Giustina, A., Korbonits, M., Bronstein, M. D., … Strasburger, C. J. (2015). Safety and efficacy of oral octreotide in acromegaly: Results of a multicenter phase III trial. Journal of Clinical Endocrinology and Metabolism, 100(4), 1699–1708.https://doi.org/10.1210/jc.2014-4113

Publication